Each month in his online column, Dr Andrade offers practical knowledge, ideas, and tips in psychopharmacology to JCP readers in psychiatric and general medical settings.
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Subclinical hypothyroidism occurs in 4%-20% of adults, depending on the population studied and the disease definition applied. 2 Clinical and subclinical hypothyroidism are sometimes observed in psychiatric disorders. For example, these endocrine states may be associated with developmental delay or mental retardation, 3 mood or cognitive disturbance in the elderly, 4 dementia, 5 psychosis, 6 depression, 7 bipolar disorder, 8 rapid-cycling mood disorder, 9 and other conditions. Hypothyroidism may also be an adverse outcome of lithium therapy. 10 Levothyroxine (T 4 ) supplementation is commonly considered in such situations and when depressed patients are medication refractory. 11 Once patients have been stabilized on T 4 therapy, the dose tends to remain constant for years. 12 However, problems could arise from situations that affect T 4 absorption, and psychiatrists may not be familiar with these pharmacokinetic matters. This article therefore examines clinically significant food and drug interactions, with specific focus on T 4 absorption after oral dosing.
The Stomach and Absorption of T 4 Most of an orally administered dose of T 4 is absorbed within 20-30 minutes, and maximal absorption occurs by 3 hours in the jejunum and ileum.
12 This implies that if nothing else is ingested within 3 hours of an oral T 4 dose, then there will be no interference with T 4 absorption.
Gastric acidity is important for the absorption of T 4 ; physiologic states associated with diminished gastric acidity and drugs that diminish gastric acidity both decrease T 4 absorption. 12 The absorption of T 4 will therefore be lower in the presence of alcoholism, atrophic gastritis, small bowel disease, or malabsorption states associated with any cause, including bariatric surgery.
12,13 Absorption of T 4 would also be diminished by proton pump inhibitors 14 and antacids. 12, 13 In theory, anticholinergic drugs, which decrease gastric acidity, 15 may also decrease T 4 absorption, although this has not yet been studied or reported. It is best, therefore, to avoid administering T 4 in proximity with drugs that reduce gastric acidity. 4 It is recommended that T 4 be taken on an empty stomach, at least half an hour before breakfast, because food interferes with the absorption of T 4 .
Food and Absorption of T
12,13 Coffee has been specially described to diminish T 4 absorption, 16 as have grapefruit juice (but not orange juice), 17, 18 papaya fruit, 19 and dietary fiber, including bran. 16 Milk and other dairy products, and perhaps other foods that are rich in calcium, may impair the bioavailability of T 4 (see the next section), although there is no formal study of the interaction.
Soy milk 20 and soy protein 21 can also substantially interfere with T 4 absorption. Administering T 4 in soft gel capsule form has been suggested as a possible way of reducing the effect of coffee on the absorption of T 4 . Circumstances that result in decreased absorption of orally ■ administered levothyroxine (T 4 ) include drugs and disorders that reduce gastric acidity; constituents of food such as fiber; items of consumption such as soy, coffee, and grapefruit juice; and drugs and supplements such as calcium, iron, sucralfate, orlistat, and phosphate binders.
Patients should therefore take T ■ 4 on an empty stomach, at a time as distant as possible from intake of food, beverages, and other medications.
If this is not feasible, possible impairment in absorption can ■ be accepted and the dose of T 4 titrated to target hormonal levels.
Medications and Absorption of T 4
Besides agents that reduce gastric acidity, many drugs have been reported to decrease T 4 absorption. The commonest are calcium and iron supplements.
12,13,23 All formulations of calcium-carbonate, acetate, and citrate-reduce T 4 absorption by about 20%-25%. 24 It has therefore been suggested that if patients receiving T 4 also need calcium supplementation, the calcium should be dosed at least 4 hours distant from the T 4 . 25 Others drugs that can impair T 4 absorption include raloxifene, 26, 27 imatinib, 28 orlistat, 29 phosphate binders such as sevelamer 30, 31 and lanthanum carbonate, 32 nutritional supplements such as chromium picolinate, 30 sucralfate, ion exchange resins, bile acid sequestrants, 12,13 and possibly ciprofloxacin. 33 Waiting 4 hours after ingestion of T 4 before giving bile acid sequestrants such as colesevelam may suffice to prevent the latter from interfering with the absorption of the former. 34 Ezetimibe does not interfere with T 4 absorption. 30 This list is not comprehensive. There have been many stray reports of interactions in which the interaction was minor or the mechanism was unknown. This article preferentially emphasizes the important interactions and provides guidance that could be expected to cover all contingencies, regardless of the interacting drug.
T 4 Supplementation and the Risk of an Unexpected Hyperthyroid State
A patient who is started on T 4 may regularly take it under circumstances of diminished absorption (eg, proximal to breakfast), and if the clinician does not know this when titrating the T 4 dose to clinical efficacy, the patient will receive a higher T 4 dose than would otherwise have been necessary. If the patient's dosing behavior later changes (eg, the patient regularly delays breakfast), resulting in improved absorption of T 4 , there is a risk that the T 4 dose will become supraphysiologic, leading to an unexpected hyperthyroid state. Proper patient education, regular inquiry about dosing behavior, and regular monitoring of cardiovascular and hormonal parameters could help clinicians remain alert to such changes.
Clinical Guidance
Patients are generally advised to take T 1. 4 early in the morning, at least 30 minutes before breakfast. It is necessary for them to understand that coffee, food, and many medications impair the absorption of T 4 and therefore they should take T 4 on an empty stomach, with a glass of water (but not coffee), at a time as distant as possible from when they take their comedications and eat their next meal. Proper advice is easy to give but not necessarily 2.
easy to follow. Some patients may rise, complete their morning rituals and routines, and leave for work, all within the span of half an hour. Others may have medication scheduling problems related to shift work. Still others may have difficulty in remembering to take their psychotropic or general medications unless these medications are taken with breakfast. T 4 absorption will probably be diminished in all of these patients. These patients should nevertheless be advised to adhere to the usual guidance as far as possible. Beyond this, the clinician should recognize that the compromised absorption of T 4 can usually be compensated for by an increase in the T 4 dose and that the appropriate dose can be discovered by titrating to target thyroidstimulating hormone (TSH) levels. Importantly, in such situations, patients should not later change their dietary or dosing habits (eg, delay or skip breakfast or shift other morning medications to the afternoon or night) lest the change result in normalization of T 4 absorption and thence to a hyperthyroid state. Or, if a change in dietary or dosing habits is inevitable, the patient should be instructed to inform the clinician, who can then down-titrate the T 4 dose on the basis of reestimation of hormonal levels. In a 6-month, randomized, double-blind, crossover 3.
trial in 105 patients with primary hypothyroidism (all of whom were on a stable dose of T 4 ), Bolk et al 35 showed that T 4 administered at bedtime was associated with lower TSH and higher free T 4 and total triiodothyronine levels relative to the same dose administered in the morning. An earlier pilot study 36 by the same team suggested that bedtime dosing of T 4 does not alter the TSH circadian rhythm. This is logical, given that T 4 has a half-life of about a week (longer, in patients with hypothyroidism). Therefore, in unusual circumstances, some thought must be given to the possibility of dosing T 4 just before bedtime, with dosing as distant from the last meal (and the last comedications) as possible. Proton pump inhibitor (PPI) use may pose a special 4.
problem. The half-life of PPIs is typically short, about an hour. However, their duration of action is considerably longer, about a day, because new H+/K+ pumps must be synthesized for fresh acid production. 37 An additional matter is that PPIs are best dosed about 20 minutes before breakfast, when they could be expected to maximally interfere with T 4 absorption as T 4 is conventionally dosed. Clinicians should be aware that in patients who go on or off PPI therapy, fluctuations in T 4 absorption could occur, with associated fluctuations in thyroid status. There may therefore be a case for bedtime dosing of T 4 in patients receiving PPI therapy. Clinicians should be aware that any sustained 5.
changes in the absorption of T 4 would result in changes in thyroid status only after a time lag of a few weeks. This is because, as already stated, T 4 has a long half-life.
Parting Notes
There are patients in whom hormonal levels show wide fluctuations in the context of a stable T 4 dose. Before suspecting issues related to absorption, clinicians must rule out poor medication adherence. Because T 4 has a long halflife, occasional missed doses (or occasional poor absorption for any reason) will not have a significant clinical impact; however, frequent nonadherence would raise TSH levels. Becoming pregnant or gaining weight could also increase T 4 need. 12 Finally, patients who switch formulations of T 4 may experience changes in the degree of adequacy of dose related to differences in bioavailability.
